価格表

在庫・価格 : 2020年07月11日 19時23分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
CD40 Ligand, Soluble, Human, ELISA Kit, Quantikine (96 well)
データシート※最新のデータシートでない場合があります
DCDL40 RSDアールアンドディー システムス
R&D Systems, Inc.(R&D Systemsは,テクネ コーポレイションの登録商標です)
1 kit ¥98,000
(未発注)
追加

在庫・価格 : 2020年07月11日 19時23分 現在

CD40 Ligand, Soluble, Human, ELISA Kit, Quantikine (96 well)

  • 商品コード:DCDL40
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥98,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Heeschen C et al. Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med. 2003 Mar;348(12):1104-11
Heeschen C et al
2003/01/01
Sample Type: Serum PubMed
2 Kim S et al. Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells. Infect. Immun. 2004 Jan;72(1):89-93
Kim S et al
2004/01/01
Sample Type: Cell Supernates PubMed
3 Roselli M et al. Soluble CD40 ligand plasma levels in lung cancer. Clin. Cancer Res. 2004 Jan;10(2):610-4
Roselli M et al
2004/01/01
Sample Type: Plasma (Citrate) PubMed
4 Netea MG et al. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur. J. Clin. Invest. 2004 Feb;34(2):94-9
Netea MG et al
2004/01/01
Sample Type: Whole Tissue PubMed
5 Morel O et al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb. Haemost. 2004 Feb;91(2):345-53
Morel O et al
2004/01/01
Sample Type: Plasma (Not Specified) PubMed
6 Solanilla A et al. Platelet-associated CD154 in immune thrombocytopenic purpura. Blood 2005 Jan;105(1):215-8
Solanilla A et al
2005/01/01
Sample Type: Cell Lysates PubMed
7 Azar RR et al. Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease. Am. J. Cardiol. 2005 Jan;95(2):23
Azar RR et al
2005/01/01
Sample Type: Serum PubMed
8 Heeschen C et al. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J. Am. Coll. Cardiol. 2005 Jan;45(2):229-37
Heeschen C et al
2005/01/01
Sample Type: Plasma (Not Specified) PubMed
9 Blann AD et al. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty. Thromb. Haemost. 2005 Mar;93(3):578-83
Blann AD et al
2005/01/01
Sample Type: Plasma (EDTA) PubMed
10 Barani J et al. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J. Vasc. Surg. 2005 Jul;42(1):75-80
Barani J et al
2005/01/01
Sample Type: Serum PubMed
11 Patrignani P et al. Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. Blood 2006 May;107(9):3572-4
Patrignani P et al
2006/01/01
Sample Type: Plasma (Not Specified) PubMed
12 Yip HK et al. Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting. Am. J. Cardiol. 2006 Jan;97(2):192-4
Yip HK et al
2006/01/01
human plasma PubMed
13 Koh KK et al. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients. Diabetes Care 2006 Feb;29(2):195-201
Koh KK et al
2006/01/01
human plasma PubMed
14 Chu CS et al. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Am. J. Cardiol. 2006 Mar;97(5):646-50
Chu CS et al
2006/01/01
human serum PubMed
15 Han SH et al. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients. Atherosclerosis 2007 Jan;190(1):205-11
Han SH et al
2007/01/01
Sample Type: Plasma (Not Specified) PubMed
16 Touat Z et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am. J. Pathol. 2006 Mar;168(3):1022-30
Touat Z et al
2006/01/01
human plasma PubMed
17 Undas A et al. Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury. Thromb. Haemost. 2006 Jun;95(6):1045-7
Undas A et al
2006/01/01
Species: Human, Sample type: Plasma (Heparin), Wound Secretion PubMed
18 Khan SY et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006 Oct;108(7):2455-62
Khan SY et al
2006/01/01
Sample Type: Plasma (Heparin),Platelet Concentrate,Whole Blood Plasma,leukoreduced packed red blood cells,packed red blood cells PubMed
19 Park HK et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006 Aug;114(9):886-93
Park HK et al
2006/01/01
Species: Human, Sample type: Plasma (Not Specified) PubMed
20 Wang TD et al. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am. J. Card
Wang TD et al
2006/01/01
Species: Human, Application: Plasma (EDTA) PubMed
21 Silliman CC et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007 Feb;109(4):1752-5
Silliman CC et al
2007/01/01
Species: Human, Sample type: Cell Lysates PubMed
22 Sherman JA et al. Humoral and cellular factors responsible for coronary collateral formation. Am. J. Cardiol. 2006 Nov;98(9):1194-7
Sherman JA et al
2006/01/01
Species: Human, Application: Plasma (Heparin) PubMed
23 Solheim S et al. No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease. Thromb. Haemost. 2006 Nov;96(5):660-4
Solheim S et al
2006/01/01
Species: Human, Sample type: Plasma (EDTA) PubMed
24 B辿dard E et al. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Stroke 2007 Jan;38(1):100-4
B辿dard E et al
2007/01/01
Species: Human, Sample type: Plasma (Citrate) PubMed
25 Desideri G et al. Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease. Am. J. Hypertens. 2007 Jan;20(1):70-6; discussion 77
Desideri G et al
2007/01/01
Sample Type: Plasma (EDTA) PubMed
26 Niccoli G et al. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2008 Feb;196(2):779-85
Niccoli G et al
2008/01/01
Species: Human, Application: Serum PubMed
27 Minoguchi K et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2007 Mar;175(6):612-7
Minoguchi K et al
2007/01/01
Sample Type: Serum PubMed
28 Apple FS et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin. Chem. 2007 May;53(5):874-81
Apple FS et al
2007/01/01
Sample Type: Plasma (Heparin) PubMed
29 Altwegg LA et al. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur. Heart J. 2007 Apr;28(8):941-8
Altwegg LA et al
2007/01/01
Species: Human, Sample type: Serum PubMed
30 Martino F et al. Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J. Am. Coll. Cardiol. 2007 May;49(19):1974-81
Martino F et al
2007/01/01
Species: Human, Sample type: Plasma (Citrate) PubMed
31 Anand SX et al. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am. J. Cardiol. 2007 Aug;100(3):4
Anand SX et al
2007/01/01
Species: Human, Sample type: Plasma (Citrate) PubMed
32 Khanolkar MP et al. Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation. Atherosclerosis 2008 A
Khanolkar MP et al
2008/01/01
Species: Human, Application: Serum PubMed
33 Ferro D et al. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler. Thromb. Vasc. Biol. 2007 Dec;27(12):2763-8
Ferro D et al
2007/01/01
Species: Human, Sample type: Plasma (Not Specified) PubMed
34 Perneby C et al. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Thromb. Haemost. 2007 Dec;98(6):1316-22
Perneby C et al
2007/01/01
Species: Human, Sample type: Plasma (Not Specified) PubMed
35 Choudhury A et al. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis? Chest 2007 Dec;132(6):1913-9
Choudhury A et al
2007/01/01
Species: Human, Sample type: Plasma (Citrate) PubMed
36 Chung I et al. The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure. Eur. J. Clin. Invest. 2008 Mar;38(3):150-8
Chung I et al
2008/01/01
Species: Human, Application: Plasma (Not Specified) PubMed
37 Undas A et al. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 2008 Aug;31(8):1590-5
Undas A et al
2008/01/01
Species: Human, Application: Plasma (Heparin) PubMed
38 Damsgaard CT et al. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J. Nutr. 2008 Jun;138(6):1061-6
Damsgaard CT et al
2008/01/01
Species: Human, Application: Serum PubMed
39 Dai DF et al. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J. Am. Coll. Cardiol. 2008 Jun;51(22):2173-80
Dai DF et al
2008/01/01
Species: Human, Application: Plasma (Heparin) PubMed
40 Choudhury A et al. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention. Chest 2008 Sep;134(3):574-81
Choudhury A et al
2008/01/01
Sample Type: Platelet-Poor Plasma (Citrate) PubMed
41 Lengell辿 J et al. Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum. Cytokine 2008 Nov;44(2):275-82
Lengell辿 J et al
2008/01/01
Sample Type: Serum PubMed
42 B辿res BJ et al. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Thromb. Haemost. 2008 Nov;100(5):829-38
B辿res BJ et al
2008/01/01
Sample Type: Plasma (Not Specified) PubMed
43 Tr淡seid M et al. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009 Mar;32(3):486-92
Tr淡seid M et al
2009/01/01
Sample Type: Plasma (EDTA) PubMed
44 Arellano-Rodrigo E et al. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. Am. J. Hematol. 2009 Feb;84(2)
Arellano-Rodrigo E et al
2009/01/01
Sample Type: Plasma (Citrate) PubMed
45 Malmstr旦m RE et al. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance. Thromb. Haemost. 2009 Jan;101(1):157-64
Malmstr旦m RE et al
2009/01/01
Sample Type: Serum PubMed
46 Plat J et al. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J. Nutr. 2009 Jun;139(6):1143-9
Plat J et al
2009/01/01
Sample Type: Plasma (EDTA) PubMed
47 Dossus L et al. Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. J. Immunol. Methods 2009 Oct;350(1-2):125-32
Dossus L et al
2009/01/01
Sample Type: Plasma (Not Specified) PubMed
48 Ray MJ et al. Pre-operative platelet-bound CD40 ligand is probably associated with peri-operative cardiac events in hip and knee arthroplasty. Eur. J. Clin. Invest. 2010 Jun;40(6):497-503
Ray MJ et al
2010/01/01
Sample Type: Plasma (Citrate) PubMed
49 Kawut SM et al. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study. Biomarkers 2010 Dec;15(8):731-8
Kawut SM et al
2010/01/01
Sample Type: Plasma (Not Specified) PubMed
50 Jefferis BJ et al. Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women. J. Thromb. Haemost. 2011 Aug;9(8):1452-9
Jefferis BJ et al
2011/01/01
Sample Type: Serum PubMed
51 Johansson PI et al. High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J. Thromb. Haemost. 2012 Feb;10(2):207-16
Johansson PI et al
2012/01/01
Sample Type: Plasma (EDTA) PubMed
52 Johansson PI et al. Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity. Crit. Care Med. 2012 Jun;40(6):1844-50
Johansson PI et al
2012/01/01
Sample Type: Plasma PubMed
53 Feng X et al. Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J. Thromb. Haemost. 2012 Aug;10(8):1616-23
Feng X et al
2012/01/01
Sample Type: Cell Culture Supernates,Platelet-Poor Plasma,Platelet-Poor Serum,Platelet-Rich Plasma,Serum PubMed
54 Dickinson RE et al. The evolution of cellular deficiency in GATA2 mutation. Blood 2014 Feb;123(6):863-74
Dickinson RE et al
2014/01/01
Sample Type: Serum PubMed
55 Fuentes E et al. Chlorogenic acid inhibits human platelet activation and thrombus formation. PLoS ONE 2014;9(3):e90699
Fuentes E et al
2014/01/01
Sample Type: cell culture supernatants PubMed
56 Fuentes E et al. Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling. PLoS ONE 2014;9(11):e112741
Fuentes E et al
2014/01/01
Sample Type: Cell Culture Supernates PubMed
57 Fuentes E et al. Protective mechanisms of guanosine from Solanum lycopersicum on agonist-induced platelet activation: role of sCD40L. Molecules 2013;18(7):8120-35
Fuentes E et al
2013/01/01
Sample Type: Platelet Concentrate PubMed
58 Kageyama Y et al. Involvement of Rac in thromboxane A2‑induced human platelet activation: regulation of sCD40 ligand release and PDGF‑AB secretion. Mol Med Rep 2014 Jul;10(1):107-12
Kageyama Y et al
2014/01/01
Sample Type: Plasma PubMed
59 Silliman CC et al. Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. Blood 2014 May;123(22):3488-95
Silliman CC et al
2014/01/01
Sample Type: Serum PubMed
60 Azzariti A et al. Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma. Onco Targets Ther 2016;9:4681-6
Azzariti A et al
2016/01/01
Sample Type: Serum PubMed
61 Chang LY et al. Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis. Sci Rep 2016 Nov;6:36862
Chang LY et al
2016/01/01
Sample Type: Plasma PubMed
62 Ruediger CD et al. Influence of ethnic background on left atrial markers of inflammation, endothelial function and tissue remodelling. Indian Pacing Electrophysiol J ;18(1):1-5
Ruediger CD et al
Species: Human PubMed
63 Szentp辿teri A et al. Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia. VASA 2017 Aug;46(5):370-376
Szentp辿teri A et al
2017/01/01
Species: Human PubMed
64 Bl叩ha V et al. Lipoprotein apheresis in the treatment of dyslipidaemia - the Czech Republic experience. Physiol Res 2017 Apr;66(Supplementum 1):S91-S100
Bl叩ha V et al
2017/01/01
PubMed
65 Lorente L et al. Non-survivor septic patients have persistently higher serum sCD40L levels than survivors. J Crit Care 2017 10;41:177-182
Lorente L et al
2017/01/01
PubMed
66 Liu ZL et al. The <i>CD40</i> rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels. Biomed Res Int 2018;2018:7497314
Liu ZL et al
2018/01/01
PubMed
  • No.: 1
  • 文献情報:
    Heeschen C et al. Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med. 2003 Mar;348(12):1104-11
    Heeschen C et al
    2003/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kim S et al. Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells. Infect. Immun. 2004 Jan;72(1):89-93
    Kim S et al
    2004/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Roselli M et al. Soluble CD40 ligand plasma levels in lung cancer. Clin. Cancer Res. 2004 Jan;10(2):610-4
    Roselli M et al
    2004/01/01
  • 備考:
    Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Netea MG et al. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur. J. Clin. Invest. 2004 Feb;34(2):94-9
    Netea MG et al
    2004/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Morel O et al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb. Haemost. 2004 Feb;91(2):345-53
    Morel O et al
    2004/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Solanilla A et al. Platelet-associated CD154 in immune thrombocytopenic purpura. Blood 2005 Jan;105(1):215-8
    Solanilla A et al
    2005/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Azar RR et al. Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease. Am. J. Cardiol. 2005 Jan;95(2):23
    Azar RR et al
    2005/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Heeschen C et al. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J. Am. Coll. Cardiol. 2005 Jan;45(2):229-37
    Heeschen C et al
    2005/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Blann AD et al. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty. Thromb. Haemost. 2005 Mar;93(3):578-83
    Blann AD et al
    2005/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Barani J et al. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J. Vasc. Surg. 2005 Jul;42(1):75-80
    Barani J et al
    2005/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Patrignani P et al. Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. Blood 2006 May;107(9):3572-4
    Patrignani P et al
    2006/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Yip HK et al. Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting. Am. J. Cardiol. 2006 Jan;97(2):192-4
    Yip HK et al
    2006/01/01
  • 備考:
    human plasma
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Koh KK et al. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients. Diabetes Care 2006 Feb;29(2):195-201
    Koh KK et al
    2006/01/01
  • 備考:
    human plasma
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Chu CS et al. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Am. J. Cardiol. 2006 Mar;97(5):646-50
    Chu CS et al
    2006/01/01
  • 備考:
    human serum
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Han SH et al. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients. Atherosclerosis 2007 Jan;190(1):205-11
    Han SH et al
    2007/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Touat Z et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am. J. Pathol. 2006 Mar;168(3):1022-30
    Touat Z et al
    2006/01/01
  • 備考:
    human plasma
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Undas A et al. Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury. Thromb. Haemost. 2006 Jun;95(6):1045-7
    Undas A et al
    2006/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Heparin), Wound Secretion
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Khan SY et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006 Oct;108(7):2455-62
    Khan SY et al
    2006/01/01
  • 備考:
    Sample Type: Plasma (Heparin),Platelet Concentrate,Whole Blood Plasma,leukoreduced packed red blood cells,packed red blood cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Park HK et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006 Aug;114(9):886-93
    Park HK et al
    2006/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Wang TD et al. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am. J. Card
    Wang TD et al
    2006/01/01
  • 備考:
    Species: Human, Application: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Silliman CC et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007 Feb;109(4):1752-5
    Silliman CC et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Sherman JA et al. Humoral and cellular factors responsible for coronary collateral formation. Am. J. Cardiol. 2006 Nov;98(9):1194-7
    Sherman JA et al
    2006/01/01
  • 備考:
    Species: Human, Application: Plasma (Heparin)
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Solheim S et al. No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease. Thromb. Haemost. 2006 Nov;96(5):660-4
    Solheim S et al
    2006/01/01
  • 備考:
    Species: Human, Sample type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    B辿dard E et al. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Stroke 2007 Jan;38(1):100-4
    B辿dard E et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Desideri G et al. Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease. Am. J. Hypertens. 2007 Jan;20(1):70-6; discussion 77
    Desideri G et al
    2007/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Niccoli G et al. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2008 Feb;196(2):779-85
    Niccoli G et al
    2008/01/01
  • 備考:
    Species: Human, Application: Serum
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Minoguchi K et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2007 Mar;175(6):612-7
    Minoguchi K et al
    2007/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Apple FS et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin. Chem. 2007 May;53(5):874-81
    Apple FS et al
    2007/01/01
  • 備考:
    Sample Type: Plasma (Heparin)
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Altwegg LA et al. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur. Heart J. 2007 Apr;28(8):941-8
    Altwegg LA et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Serum
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Martino F et al. Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J. Am. Coll. Cardiol. 2007 May;49(19):1974-81
    Martino F et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Anand SX et al. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am. J. Cardiol. 2007 Aug;100(3):4
    Anand SX et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Khanolkar MP et al. Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation. Atherosclerosis 2008 A
    Khanolkar MP et al
    2008/01/01
  • 備考:
    Species: Human, Application: Serum
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Ferro D et al. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler. Thromb. Vasc. Biol. 2007 Dec;27(12):2763-8
    Ferro D et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Perneby C et al. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Thromb. Haemost. 2007 Dec;98(6):1316-22
    Perneby C et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Choudhury A et al. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis? Chest 2007 Dec;132(6):1913-9
    Choudhury A et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Chung I et al. The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure. Eur. J. Clin. Invest. 2008 Mar;38(3):150-8
    Chung I et al
    2008/01/01
  • 備考:
    Species: Human, Application: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Undas A et al. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 2008 Aug;31(8):1590-5
    Undas A et al
    2008/01/01
  • 備考:
    Species: Human, Application: Plasma (Heparin)
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Damsgaard CT et al. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J. Nutr. 2008 Jun;138(6):1061-6
    Damsgaard CT et al
    2008/01/01
  • 備考:
    Species: Human, Application: Serum
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Dai DF et al. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J. Am. Coll. Cardiol. 2008 Jun;51(22):2173-80
    Dai DF et al
    2008/01/01
  • 備考:
    Species: Human, Application: Plasma (Heparin)
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Choudhury A et al. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention. Chest 2008 Sep;134(3):574-81
    Choudhury A et al
    2008/01/01
  • 備考:
    Sample Type: Platelet-Poor Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Lengell辿 J et al. Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum. Cytokine 2008 Nov;44(2):275-82
    Lengell辿 J et al
    2008/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    B辿res BJ et al. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Thromb. Haemost. 2008 Nov;100(5):829-38
    B辿res BJ et al
    2008/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Tr淡seid M et al. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009 Mar;32(3):486-92
    Tr淡seid M et al
    2009/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Arellano-Rodrigo E et al. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. Am. J. Hematol. 2009 Feb;84(2)
    Arellano-Rodrigo E et al
    2009/01/01
  • 備考:
    Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Malmstr旦m RE et al. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance. Thromb. Haemost. 2009 Jan;101(1):157-64
    Malmstr旦m RE et al
    2009/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Plat J et al. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J. Nutr. 2009 Jun;139(6):1143-9
    Plat J et al
    2009/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Dossus L et al. Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. J. Immunol. Methods 2009 Oct;350(1-2):125-32
    Dossus L et al
    2009/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Ray MJ et al. Pre-operative platelet-bound CD40 ligand is probably associated with peri-operative cardiac events in hip and knee arthroplasty. Eur. J. Clin. Invest. 2010 Jun;40(6):497-503
    Ray MJ et al
    2010/01/01
  • 備考:
    Sample Type: Plasma (Citrate)
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Kawut SM et al. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study. Biomarkers 2010 Dec;15(8):731-8
    Kawut SM et al
    2010/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Jefferis BJ et al. Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women. J. Thromb. Haemost. 2011 Aug;9(8):1452-9
    Jefferis BJ et al
    2011/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Johansson PI et al. High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J. Thromb. Haemost. 2012 Feb;10(2):207-16
    Johansson PI et al
    2012/01/01
  • 備考:
    Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Johansson PI et al. Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity. Crit. Care Med. 2012 Jun;40(6):1844-50
    Johansson PI et al
    2012/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Feng X et al. Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J. Thromb. Haemost. 2012 Aug;10(8):1616-23
    Feng X et al
    2012/01/01
  • 備考:
    Sample Type: Cell Culture Supernates,Platelet-Poor Plasma,Platelet-Poor Serum,Platelet-Rich Plasma,Serum
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Dickinson RE et al. The evolution of cellular deficiency in GATA2 mutation. Blood 2014 Feb;123(6):863-74
    Dickinson RE et al
    2014/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Fuentes E et al. Chlorogenic acid inhibits human platelet activation and thrombus formation. PLoS ONE 2014;9(3):e90699
    Fuentes E et al
    2014/01/01
  • 備考:
    Sample Type: cell culture supernatants
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Fuentes E et al. Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling. PLoS ONE 2014;9(11):e112741
    Fuentes E et al
    2014/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Fuentes E et al. Protective mechanisms of guanosine from Solanum lycopersicum on agonist-induced platelet activation: role of sCD40L. Molecules 2013;18(7):8120-35
    Fuentes E et al
    2013/01/01
  • 備考:
    Sample Type: Platelet Concentrate
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Kageyama Y et al. Involvement of Rac in thromboxane A2&#x2011;induced human platelet activation: regulation of sCD40 ligand release and PDGF&#x2011;AB secretion. Mol Med Rep 2014 Jul;10(1):107-12
    Kageyama Y et al
    2014/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Silliman CC et al. Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. Blood 2014 May;123(22):3488-95
    Silliman CC et al
    2014/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Azzariti A et al. Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma. Onco Targets Ther 2016;9:4681-6
    Azzariti A et al
    2016/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Chang LY et al. Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis. Sci Rep 2016 Nov;6:36862
    Chang LY et al
    2016/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Ruediger CD et al. Influence of ethnic background on left atrial markers of inflammation, endothelial function and tissue remodelling. Indian Pacing Electrophysiol J ;18(1):1-5
    Ruediger CD et al
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Szentp辿teri A et al. Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia. VASA 2017 Aug;46(5):370-376
    Szentp辿teri A et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Bl叩ha V et al. Lipoprotein apheresis in the treatment of dyslipidaemia - the Czech Republic experience. Physiol Res 2017 Apr;66(Supplementum 1):S91-S100
    Bl叩ha V et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Lorente L et al. Non-survivor septic patients have persistently higher serum sCD40L levels than survivors. J Crit Care 2017 10;41:177-182
    Lorente L et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Liu ZL et al. The <i>CD40</i> rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels. Biomed Res Int 2018;2018:7497314
    Liu ZL et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed